Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock Rating Lowered by StockNews.com
Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday. Other equities research analysts have also recently issued research reports about the stock. Barclays reiterated an “overweight” rating and set a $200.00 target price […]
Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday. Other equities research analysts have also recently issued research reports about the stock. Barclays reiterated an “overweight” rating and set a $200.00 target price […]
